Meeting
2020 ASCO Virtual Scientific Program
Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
Authors
Yutaro Tamiya
National Cancer Center Hospital East, Kashiwa, Japan
Yutaro Tamiya , Yoshitaka Zenke , Shingo Matsumoto , Naoki Furuya , Tomohiro Sakamoto , Terufumi Kato , Kazumi Nishino , Masato Shingyoji , Shingo Miyamoto , Chigusa Shirakawa , Ryo Toyozawa , Kadoaki Ohashi , Takaya Ikeda , Kaname Nosaki , Hibiki Udagawa , Keisuke Kirita , Kiyotaka Yoh , Seiji Niho , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9589)
DOI
10.1200/JCO.2020.38.15_suppl.9589
Abstract #
9589
Poster Bd #
355
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinico-pathological and genomic features of NRAS- or HRAS-mutated non-small cell lung cancer (NSCLC) identified in large-scale genomic screening project (LC-SCRUM-Asia).
First Author: Yutaro Tamiya
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen
Poster
2020 ASCO Virtual Scientific Program
Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
First Author: Stephen V. Liu